|Day Low/High||88.23 / 91.33|
|52 Wk Low/High||61.61 / 100.00|
Movement has become difficult after weeks of advances, which suggests a downturn may be near.
Jim Cramer believes Abbott Labs' CEO Miles White is doing a terrific job of making the company better.
The Russell 2000's failure to follow the S&P and Dow's lead is only one reason for concern.
Shares of Alere soared on Monday on word that Abbott Labs would acquire the company in a deal valued at $7.9 billion.
Two significant, but subtle forces may threaten the group in the next 12 months.
The merged company can become multiple companies.
Peter Boockvar looks at China, the European Central Bank and the Bank of Japan this morning: "According to the Chinese, their economy grew 6.9% y/o/y in the third quarter vs. 7% in the second quarter and vs. a 6.8% estimate. While we'll take that wi...
Before you sell them, ask yourself at what multiple you sell.
Stocks climbed early Thursday, but Jim Cramer, portfolio manager of Action Alerts PLUS, remains cautious still.
IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..
This market is almost entirely special situation.
Duke Energy's recent increase puts its payout at the high end of the industry range.
As health-care stocks rally, it's time for politicians to move on.
The ABBV chart looks constructive, with solid volume and bullish indicators.
Durable Goods orders fell a half percent in April matching estimates.
You could throw darts at financials and health care and win.